These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38471722)

  • 21. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
    Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
    Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
    J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells.
    Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J
    Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
    Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
    Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
    Moritoki M; Kadowaki T; Niki T; Nakano D; Soma G; Mori H; Kobara H; Masaki T; Kohno M; Hirashima M
    PLoS One; 2013; 8(4):e60807. PubMed ID: 23585851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
    Duan X; Shen C; Zhang X; Wu L; Chen J; Ma B; Wang Q; Sun P; Lan Y; Su C
    Int Immunopharmacol; 2020 Mar; 80():106239. PubMed ID: 32007709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
    Dai H; He F; Tsokos GC; Kyttaris VC
    J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice.
    Iwata Y; Wada T; Furuichi K; Sakai N; Matsushima K; Yokoyama H; Kobayashi K
    J Am Soc Nephrol; 2003 Jan; 14(1):57-67. PubMed ID: 12506138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 contributes to high level IgG production in the murine MRL/lpr lupus model.
    Singh AK; Lebedeva TV
    Immunol Invest; 1994 Aug; 23(4-5):281-92. PubMed ID: 7959962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.